Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Wednesday's Intraday Session

Author: Benzinga Insights | October 25, 2023 01:31pm

Gainers

  • Werewolf Therapeutics (NASDAQ:HOWL) shares rose 30.0% to $2.34 during Wednesday's regular session. As of 13:30 EST, this security is trading at a volume of 1.4 million shares, making up 4222.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $83.4 million.
  • Reshape Lifesciences (NASDAQ:RSLS) stock moved upwards by 24.06% to $0.26. Trading volume for this security as of 13:30 EST is 46.7 million, which is 2583.2% of its average full-day volume over the last 100 days. The company's market cap stands at $1.3 million.
  • BioXcel Therapeutics (NASDAQ:BTAI) shares rose 17.94% to $2.76. The current volume of 63.0 million shares is 4607.2% of BioXcel Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $80.7 million.
  • iSpecimen (NASDAQ:ISPC) stock moved upwards by 16.66% to $0.56. The company's market cap stands at $5.0 million.
  • Titan Pharma (NASDAQ:TTNP) shares increased by 16.5% to $0.43. Trading volume for this security as of 13:30 EST is 170.4K, which is 181.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.4 million.
  • Catalyst Biosciences (NASDAQ:CBIO) stock moved upwards by 15.95% to $0.5. Trading volume for Catalyst Biosciences's stock is 303.2K as of 13:30 EST. This is 77.1% of its average full-day volume over the last 100 days. The company's market cap stands at $18.9 million.

Losers

  • Sonnet BioTherapeutics (NASDAQ:SONN) stock declined by 29.6% to $1.27 during Wednesday's regular session. As of 13:30 EST, Sonnet BioTherapeutics's stock is trading at a volume of 617.5K, which is 874.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.2 million.
  • Motus GI Hldgs (NASDAQ:MOTS) shares fell 23.65% to $0.51. Trading volume for this security as of 13:30 EST is 413.2K, which is 275.6% of its average full-day volume over the last 100 days. The company's market cap stands at $3.0 million.
  • Cibus (NASDAQ:CBUS) stock declined by 22.94% to $10.65. Cibus's stock is trading at a volume of 312.3K shares as of 13:30 EST. This is 528.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $177.2 million.
  • DarioHealth (NASDAQ:DRIO) stock decreased by 22.34% to $1.6. The current volume of 231.4K shares is 204.6% of DarioHealth's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $43.5 million.
  • Heart Test Laboratories (NASDAQ:HSCS) shares fell 20.63% to $0.24. Trading volume for Heart Test Laboratories's stock is 152.4K as of 13:30 EST. This is 153.1% of its average full-day volume over the last 100 days. The company's market cap stands at $2.6 million.
  • Tharimmune (NASDAQ:THAR) stock decreased by 20.01% to $0.2. Trading volume for Tharimmune's stock is 1.3 million as of 13:30 EST. This is 55.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $3.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BTAI CBIO CBUS DRIO HOWL HSCS ISPC MOTS RSLS SONN THAR TTNP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist